We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives.
- Authors
Jacquelot, Nicolas; Seillet, Cyril; Souza-Fonseca-Guimaraes, Fernando; Sacher, Adrian G.; Belz, Gabrielle T.; Ohashi, Pamela S.
- Abstract
Natural killer (NK) cells and type 1 innate lymphoid cells (ILC1) are specific innate lymphoid cell subsets that are key for the detection and elimination of pathogens and cancer cells. In liver, while they share a number of characteristics, they differ in many features. These include their developmental pathways, tissue distribution, phenotype and functions. NK cells and ILC1 contribute to organ homeostasis through the production of key cytokines and chemokines and the elimination of potential harmful bacteria and viruses. In addition, they are equipped with a wide range of receptors, allowing them to detect "stressed cells' such as cancer cells. Our understanding of the role of innate lymphoid cells in hepatocellular carcinoma (HCC) is growing owing to the development of mouse models, the progress in immunotherapeutic treatment and the recent use of scRNA sequencing analyses. In this review, we summarize the current understanding of NK cells and ILC1 in hepatocellular carcinoma and discuss future strategies to take advantage of these innate immune cells in anti-tumor immunity. Immunotherapies hold great promise in HCC, and a better understanding of the role and function of NK cells and ILC1 in liver cancer could pave the way for new NK cell and/or ILC1-targeted treatment.
- Subjects
INNATE lymphoid cells; HEPATOCELLULAR carcinoma; LABORATORY mice; LIVER cells; LIVER cancer; KILLER cells
- Publication
International Journal of Molecular Sciences, 2021, Vol 22, Issue 16, p9044
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms22169044